Drug Profile
Estradiol/norethisterone continuous transdermal - Elan Pharma
Latest Information Update: 08 Feb 2019
Price :
$50
*
At a glance
- Originator Elan Pharma International
- Developer Pfizer
- Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Norpregnenes; Oral contraceptives; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome
Most Recent Events
- 08 Feb 2019 Chemical structure information added
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
- 05 Apr 2000 Monsanto has merged with Pharmacia & Upjohn to form Pharmacia Corporation